467 related articles for article (PubMed ID: 15667543)
1. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
[TBL] [Abstract][Full Text] [Related]
2. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
Schiffner R; Glässl A; Landthaler M; Stolz W
Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
[No Abstract] [Full Text] [Related]
3. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
Irion R; Gall H; Peter RU
Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
[No Abstract] [Full Text] [Related]
4. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
[TBL] [Abstract][Full Text] [Related]
5. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
Koch P
Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
[TBL] [Abstract][Full Text] [Related]
6. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.
Boehncke WH; Weber L; Gall H
Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822
[TBL] [Abstract][Full Text] [Related]
7. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
Trautmann A; Seitz CS
Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
[TBL] [Abstract][Full Text] [Related]
8. The complex clinical picture of side effects to anticoagulation.
Trautmann A; Seitz CS
Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
[TBL] [Abstract][Full Text] [Related]
9. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
[No Abstract] [Full Text] [Related]
10. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
Figarella I; Barbaud A; Lecompte T; De Maistre E; Reichert-Penetrat S; Schmutz JL
Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
[TBL] [Abstract][Full Text] [Related]
12. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K
Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
[TBL] [Abstract][Full Text] [Related]
13. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration.
Jappe U; Reinhold D; Bonnekoh B
Contact Dermatitis; 2002 Jan; 46(1):29-32. PubMed ID: 11918584
[TBL] [Abstract][Full Text] [Related]
14. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
Grassegger A; Fritsch P; Reider N
Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
[TBL] [Abstract][Full Text] [Related]
15. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary.
Gómez-Outes A; Gómez de la Bárcena C; Martínez-González J
Br J Dermatol; 2008 Apr; 158(4):869-70. PubMed ID: 18284394
[No Abstract] [Full Text] [Related]
16. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
[No Abstract] [Full Text] [Related]
17. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
[TBL] [Abstract][Full Text] [Related]
18. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
Liew G; Campbell C; Thursby P
ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
[No Abstract] [Full Text] [Related]
19. Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.
Tan E; Thompson G; Ekstrom C; Lucas M
Intern Med J; 2018 Jan; 48(1):73-77. PubMed ID: 29314514
[TBL] [Abstract][Full Text] [Related]
20. [Delayed-type allergy for heparin and fractions of low-molecular-weight heparin].
de Kort WJ; van der Meer YG; de Groot AC
Ned Tijdschr Geneeskd; 1992 Nov; 136(48):2379-80. PubMed ID: 1334235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]